Skip to main content
Erschienen in: Osteoporosis International 1/2010

01.01.2010 | Original Article

The potential impact of new National Osteoporosis Foundation guidance on treatment patterns

verfasst von: B. Dawson-Hughes, A. C. Looker, A. N. A. Tosteson, H. Johansson, J. A. Kanis, L. J. Melton III

Erschienen in: Osteoporosis International | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

Summary

This analysis of National Health and Nutrition Examination Survey III data describes the prevalence of risk factors for osteoporosis and the proportions of men and postmenopausal women age 50 years and older who are candidates for treatment to lower fracture risk, according to the new FRAX®-based National Osteoporosis Foundation Clinician's Guide.

Introduction

Little information is available on prevalence of osteoporosis risk factors or proportions of US men and women who are potential candidates for treatment.

Methods

The prevalence of risk factors used in the new National Osteoporosis Foundation (NOF) FRAX®-based Guide to the Prevention and Treatment of Osteoporosis was estimated using data from the third National Health and Nutrition Examination Survey (NHANES III). Risk factors not measured in NHANES III were simulated using World Health Organization cohorts. The proportion of US men and postmenopausal women age 50+ years who are treatment candidates by the new NOF Guide were calculated; for non-Hispanic white (NHW) women, the proportion eligible by the new NOF Guide was compared with that based on an earlier NOF Guide.

Results

Twenty percent of men and 37% of women were potential candidates for treatment to prevent fractures by the new NOF Guide. Among NHW women, 53% were potential candidates by the previous NOF Guide compared with 41% by the new guide.

Conclusions

One fifth of men and 37% of postmenopausal women are eligible for osteoporosis treatment consideration by the new NOF Guide. However, fewer NHW women are eligible by the new guide than by the previous NOF Guide.
Literatur
1.
Zurück zum Zitat Gehlbach SH, Avrunin JS, Puleo E (2007) Trends in hospital care for hip fractures. Osteoporos Int 18:585–591CrossRefPubMed Gehlbach SH, Avrunin JS, Puleo E (2007) Trends in hospital care for hip fractures. Osteoporos Int 18:585–591CrossRefPubMed
2.
Zurück zum Zitat Melton LJ 3rd, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL (2009) Secular trends in hip fracture incidence and recurrence. Osteoporos Int 20:687–694CrossRefPubMed Melton LJ 3rd, Kearns AE, Atkinson EJ, Bolander ME, Achenbach SJ, Huddleston JM, Therneau TM, Leibson CL (2009) Secular trends in hip fracture incidence and recurrence. Osteoporos Int 20:687–694CrossRefPubMed
3.
Zurück zum Zitat Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22:465–475CrossRefPubMed
4.
Zurück zum Zitat National Osteoporosis Foundation (2008) Clinician's Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation, Washington, D C, pp 1–36 National Osteoporosis Foundation (2008) Clinician's Guide to Prevention and Treatment of Osteoporosis. National Osteoporosis Foundation, Washington, D C, pp 1–36
5.
Zurück zum Zitat Kanis J (2008) Assessment of osteoporosis at the primary health-care level. WHO Collaborating Centre, University of Sheffield, Sheffield, UK In Group WHOS Kanis J (2008) Assessment of osteoporosis at the primary health-care level. WHO Collaborating Centre, University of Sheffield, Sheffield, UK In Group WHOS
6.
Zurück zum Zitat Tosteson AN, Melton LJ 3rd, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, Lindsay RL (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19:437–447CrossRefPubMed Tosteson AN, Melton LJ 3rd, Dawson-Hughes B, Baim S, Favus MJ, Khosla S, Lindsay RL (2008) Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int 19:437–447CrossRefPubMed
7.
Zurück zum Zitat National Osteoporosis Foundation (2005) Physician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC National Osteoporosis Foundation (2005) Physician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC
8.
Zurück zum Zitat Eddy DM, Johnston CC Jr, Cummings SR (1998) Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int 8:S1–S88CrossRef Eddy DM, Johnston CC Jr, Cummings SR (1998) Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int 8:S1–S88CrossRef
9.
Zurück zum Zitat Gunter EW, Lewis BG, Koncikowski SM (1996) Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. In Services DoHaH (ed). Center for Disease Control and Prevention, Atlanta, GA Gunter EW, Lewis BG, Koncikowski SM (1996) Laboratory procedures used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. In Services DoHaH (ed). Center for Disease Control and Prevention, Atlanta, GA
10.
Zurück zum Zitat (1977) Standards and guidelines for federal statistics: race and ethnic standards for federal statistics and administrative reporting. In Budget OoMa (ed). Federal Register. (1977) Standards and guidelines for federal statistics: race and ethnic standards for federal statistics and administrative reporting. In Budget OoMa (ed). Federal Register.
11.
Zurück zum Zitat Wahner HW, Looker A, Dunn WL, Walters LC, Hauser MF, Novak C (1994) Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers. J Bone Miner Res 9:951–960PubMedCrossRef Wahner HW, Looker A, Dunn WL, Walters LC, Hauser MF, Novak C (1994) Quality control of bone densitometry in a national health survey (NHANES III) using three mobile examination centers. J Bone Miner Res 9:951–960PubMedCrossRef
12.
Zurück zum Zitat Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay R (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–489CrossRefPubMed Looker AC, Wahner HW, Dunn WL, Calvo MS, Harris TB, Heyse SP, Johnston CC Jr, Lindsay R (1998) Updated data on proximal femur bone mineral levels of US adults. Osteoporos Int 8:468–489CrossRefPubMed
13.
Zurück zum Zitat McKinlay SM (1994) Issues in design, measurement, and analysis for menopause research. Exp Gerontol 29:479–493CrossRefPubMed McKinlay SM (1994) Issues in design, measurement, and analysis for menopause research. Exp Gerontol 29:479–493CrossRefPubMed
14.
Zurück zum Zitat Denniston PL, Epner JA (1993) 1993 physicians' GenRx. Data Pharmaceutica, New York Denniston PL, Epner JA (1993) 1993 physicians' GenRx. Data Pharmaceutica, New York
15.
Zurück zum Zitat Hansen MA, Overgaard K, Riis BJ, Christiansen C (1991) Potential risk factors for development of postmenopausal osteoporosis—examined over a 12-year period. Osteoporos Int 1:95–102CrossRefPubMed Hansen MA, Overgaard K, Riis BJ, Christiansen C (1991) Potential risk factors for development of postmenopausal osteoporosis—examined over a 12-year period. Osteoporos Int 1:95–102CrossRefPubMed
16.
Zurück zum Zitat Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC (2003) Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 48:917–926CrossRefPubMed Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC (2003) Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum 48:917–926CrossRefPubMed
17.
Zurück zum Zitat Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15–25CrossRefPubMed Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum 58:15–25CrossRefPubMed
18.
Zurück zum Zitat Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046CrossRefPubMed Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Hans D, Krieg MA, La Croix A, McCloskey E, Mellstrom D, Melton LJ 3rd, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033–1046CrossRefPubMed
19.
Zurück zum Zitat Ettinger D, Black D, Dawson-Hughes B, Pressman AR, Melton LJ (2009) Updated fracture incidence rates for the U.S. version of FRAXR. Osteoporos Int doi:10.1007/s00198-009-1032-9 Ettinger D, Black D, Dawson-Hughes B, Pressman AR, Melton LJ (2009) Updated fracture incidence rates for the U.S. version of FRAXR. Osteoporos Int doi:10.​1007/​s00198-009-1032-9
20.
Zurück zum Zitat Montori VM, Guyatt GH (2001) What is evidence-based medicine and why should it be practiced? Respir Care 46:1201–1214PubMed Montori VM, Guyatt GH (2001) What is evidence-based medicine and why should it be practiced? Respir Care 46:1201–1214PubMed
21.
Zurück zum Zitat O'Connor AM, Wennberg JE, Legare F, Llewellyn-Thomas HA, Moulton BW, Sepucha KR, Sodano AG, King JS (2007) Toward the ‘tipping point’: decision aids and informed patient choice. Health Aff (Millwood) 26:716–725CrossRef O'Connor AM, Wennberg JE, Legare F, Llewellyn-Thomas HA, Moulton BW, Sepucha KR, Sodano AG, King JS (2007) Toward the ‘tipping point’: decision aids and informed patient choice. Health Aff (Millwood) 26:716–725CrossRef
22.
Zurück zum Zitat Curtis JR, Carbone L, Cheng H, Hayes B, Laster A, Matthews R, Saag KG, Sepanski R, Tanner SB, Delzell E (2008) Longitudinal trends in use of bone mass measurement among older Americans, 1999–2005. J Bone Miner Res 23:1061–1067CrossRefPubMed Curtis JR, Carbone L, Cheng H, Hayes B, Laster A, Matthews R, Saag KG, Sepanski R, Tanner SB, Delzell E (2008) Longitudinal trends in use of bone mass measurement among older Americans, 1999–2005. J Bone Miner Res 23:1061–1067CrossRefPubMed
23.
Zurück zum Zitat Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D (2002) Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham heart study. JAMA 287:1003–1010CrossRefPubMed Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D (2002) Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham heart study. JAMA 287:1003–1010CrossRefPubMed
24.
Zurück zum Zitat Donaldson MG, Cawthon PM, Lui LY, Schousboe JT, Ensrud KE, Taylor BC, Cauley JA, Hillier TA, Black DM, Bauer DC, Cummings SR (2009) Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. national osteoporosis foundation guidelines. J Bone Miner Res 24:675–680CrossRefPubMed Donaldson MG, Cawthon PM, Lui LY, Schousboe JT, Ensrud KE, Taylor BC, Cauley JA, Hillier TA, Black DM, Bauer DC, Cummings SR (2009) Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. national osteoporosis foundation guidelines. J Bone Miner Res 24:675–680CrossRefPubMed
25.
Zurück zum Zitat Dawson-Hughes B, Harris SS, Dallal GE, Lancaster DR, Zhou Q (2002) Calcium supplement and bone medication use in a US medicare health maintenance organization. Osteoporos Int 13:657–662CrossRefPubMed Dawson-Hughes B, Harris SS, Dallal GE, Lancaster DR, Zhou Q (2002) Calcium supplement and bone medication use in a US medicare health maintenance organization. Osteoporos Int 13:657–662CrossRefPubMed
26.
Zurück zum Zitat Lee E, Wutoh AK, Xue Z, Hillman JJ, Zuckerman IH (2006) Osteoporosis management in a Medicaid population after the Women's Health Initiative study. J Womens Health (Larchmt) 15:155–161CrossRef Lee E, Wutoh AK, Xue Z, Hillman JJ, Zuckerman IH (2006) Osteoporosis management in a Medicaid population after the Women's Health Initiative study. J Womens Health (Larchmt) 15:155–161CrossRef
27.
Zurück zum Zitat Tosteson AN, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM, Pressman AR, Ettinger B (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209–216CrossRefPubMed Tosteson AN, Grove MR, Hammond CS, Moncur MM, Ray GT, Hebert GM, Pressman AR, Ettinger B (2003) Early discontinuation of treatment for osteoporosis. Am J Med 115:209–216CrossRefPubMed
28.
Zurück zum Zitat Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414–2419CrossRefPubMed Solomon DH, Avorn J, Katz JN, Finkelstein JS, Arnold M, Polinski JM, Brookhart MA (2005) Compliance with osteoporosis medications. Arch Intern Med 165:2414–2419CrossRefPubMed
29.
Zurück zum Zitat Feldstein AC, Schneider J, Smith DH, Vollmer WM, Rix M, Glauber H, Boardman DL, Herson M (2008) Harnessing stakeholder perspectives to improve the care of osteoporosis after a fracture. Osteoporos Int 19:1527–1540CrossRefPubMed Feldstein AC, Schneider J, Smith DH, Vollmer WM, Rix M, Glauber H, Boardman DL, Herson M (2008) Harnessing stakeholder perspectives to improve the care of osteoporosis after a fracture. Osteoporos Int 19:1527–1540CrossRefPubMed
30.
Zurück zum Zitat Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Int Med 162:2217–2222CrossRef Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH (2002) Undertreatment of osteoporosis in men with hip fracture. Arch Int Med 162:2217–2222CrossRef
31.
Zurück zum Zitat Cadarette SM, Katz JN, Brookhart MA, Levin R, Stedman MR, Choudhry NK, Solomon DH (2008) Trends in drug prescribing for osteoporosis after hip fracture, 1995–2004. J Rheumatol 35:319–326PubMed Cadarette SM, Katz JN, Brookhart MA, Levin R, Stedman MR, Choudhry NK, Solomon DH (2008) Trends in drug prescribing for osteoporosis after hip fracture, 1995–2004. J Rheumatol 35:319–326PubMed
32.
Zurück zum Zitat Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 291:2847–2850CrossRefPubMed Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 291:2847–2850CrossRefPubMed
33.
Zurück zum Zitat Looker AC, Pfeiffer CM, Lacher DA et al (2008) Serum 25-hydroxyvitamin D status of the US population: 1988–1994 compared with 2000–2004. Am J Clin Nutr 88:1519–1527CrossRefPubMed Looker AC, Pfeiffer CM, Lacher DA et al (2008) Serum 25-hydroxyvitamin D status of the US population: 1988–1994 compared with 2000–2004. Am J Clin Nutr 88:1519–1527CrossRefPubMed
Metadaten
Titel
The potential impact of new National Osteoporosis Foundation guidance on treatment patterns
verfasst von
B. Dawson-Hughes
A. C. Looker
A. N. A. Tosteson
H. Johansson
J. A. Kanis
L. J. Melton III
Publikationsdatum
01.01.2010
Verlag
Springer-Verlag
Erschienen in
Osteoporosis International / Ausgabe 1/2010
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-009-1034-7

Weitere Artikel der Ausgabe 1/2010

Osteoporosis International 1/2010 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.